Cargando…
Effects of Arsenic Trioxide on Minor Progressive High-Grade Osteosarcoma of the Extremities Metastatic to the Lung: Results of 39 Patients Treated in a Single Institution
Patients who mildly progressed after first-line chemotherapy were administered arsenic trioxide (ATO) 5–10 mg intravenously daily. Thirty-nine patients were finally enrolled in the study, of whom 19 patients received first-line chemotherapy with ATO infusion while 20 patients did not. Progression-fr...
Autores principales: | Xie, Lu, Guo, Wei, Tang, Xiaodong, Yang, Yi, Xu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118832/ https://www.ncbi.nlm.nih.gov/pubmed/27920692 http://dx.doi.org/10.1159/000448705 |
Ejemplares similares
-
Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma
por: Feng, Chao, et al.
Publicado: (2019) -
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study
por: Savlı, Hakan, et al.
Publicado: (2015) -
Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation
por: Nakamura, Shunsuke, et al.
Publicado: (2013) -
Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011) -
Decrease in stathmin expression by arsenic trioxide inhibits the proliferation and invasion of osteosarcoma cells via the MAPK signal pathway
por: Feng, Tao, et al.
Publicado: (2017)